Description
An antagonist of LXRα and LXRβ (IC50s = 0.1 and 0.398 µM, respectively); inhibits LXR agonist-induced and basal expression of ABCA1 and SREBP-1c in THP-1 and HepG2 cells; binds promiscuously to a variety of nuclear receptors including RORγ, RXRα, ERα, and ERβ in a nuclear receptor specificity assay in HEK293 cells; induces the expression of fatty acid synthase and SREBP-1 in a mouse model of NAFLD
Formal name: 2,4,6-trimethyl-N-[[3′-(methylsulfonyl)[1,1′-biphenyl]-4-yl]methyl]-N-[[5-(trifluoromethyl)-2-furanyl]methyl]-benzenesulfonamide
Synonyms:
Molecular weight: 591.7
CAS: 1221277-90-2
Purity: ≥98%
Formulation: A solid
Product Type|Biochemicals|Receptor Pharmacology|Antagonists||Research Area|Endocrinology & Metabolism|Hormones & Receptors|FXRs & LXRs||Research Area|Endocrinology & Metabolism|Metabolic Diseases|NAFLD & NASH